Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Antibody-drug Conjugate market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Antibody-drug Conjugate market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Antibody-drug Conjugate market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Antibody-drug Conjugate products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Antibody-drug Conjugate products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Antibody-drug Conjugate market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Antibody-drug Conjugate development has been the leading industry trend of Antibody-drug Conjugate market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Antibody-drug Conjugate Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Adcetris,Kadcyla, Other |
| By Application Outlook |
Breast Cancer,Lymphoma, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Agensys,Concortis Biotherapeutics,Sanofi,Celldex Therapeutics,Synthon Holding BV |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Agensys
- Concortis Biotherapeutics
- Sanofi
- Celldex Therapeutics
- Synthon Holding BV
Antibody-drug Conjugate Market, By Type
Antibody-drug Conjugate Market, By Application
- Breast Cancer
- Lymphoma
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antibody-drug Conjugate Market Size Growth Rate by Type (2019-2025)
1.3.2 Adcetris
1.3.3 Kadcyla
1.4 Market Segment by Application
1.4.1 Global Antibody-drug Conjugate Market Share by Application (2019-2025)
1.4.2 Breast Cancer
1.4.3 Lymphoma
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody-drug Conjugate Market Size
2.1.1 Global Antibody-drug Conjugate Revenue 2014-2025
2.1.2 Global Antibody-drug Conjugate Sales 2014-2025
2.2 Antibody-drug Conjugate Growth Rate by Regions
2.2.1 Global Antibody-drug Conjugate Sales by Regions 2014-2019
2.2.2 Global Antibody-drug Conjugate Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antibody-drug Conjugate Sales by Manufacturers
3.1.1 Antibody-drug Conjugate Sales by Manufacturers 2014-2019
3.1.2 Antibody-drug Conjugate Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Antibody-drug Conjugate Revenue by Manufacturers (2014-2019)
3.2.2 Antibody-drug Conjugate Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antibody-drug Conjugate Market Concentration Ratio (CR5 and HHI)
3.3 Antibody-drug Conjugate Price by Manufacturers
3.4 Key Manufacturers Antibody-drug Conjugate Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
3.6 Key Manufacturers Antibody-drug Conjugate Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Adcetris Sales and Revenue (2014-2019)
4.1.2 Kadcyla Sales and Revenue (2014-2019)
4.2 Global Antibody-drug Conjugate Sales Market Share by Type
4.3 Global Antibody-drug Conjugate Revenue Market Share by Type
4.4 Antibody-drug Conjugate Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antibody-drug Conjugate Sales by Application
6 United States
6.1 United States Antibody-drug Conjugate Breakdown Data by Company
6.2 United States Antibody-drug Conjugate Breakdown Data by Type
6.3 United States Antibody-drug Conjugate Breakdown Data by Application
7 European Union
7.1 European Union Antibody-drug Conjugate Breakdown Data by Company
7.2 European Union Antibody-drug Conjugate Breakdown Data by Type
7.3 European Union Antibody-drug Conjugate Breakdown Data by Application
8 China
8.1 China Antibody-drug Conjugate Breakdown Data by Company
8.2 China Antibody-drug Conjugate Breakdown Data by Type
8.3 China Antibody-drug Conjugate Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antibody-drug Conjugate Breakdown Data by Company
9.2 Rest of World Antibody-drug Conjugate Breakdown Data by Type
9.3 Rest of World Antibody-drug Conjugate Breakdown Data by Application
9.4 Rest of World Antibody-drug Conjugate Breakdown Data by Countries
9.4.1 Rest of World Antibody-drug Conjugate Sales by Countries
9.4.2 Rest of World Antibody-drug Conjugate Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Agensys
10.1.1 Agensys Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.1.4 Antibody-drug Conjugate Product Introduction
10.1.5 Agensys Recent Development
10.2 Concortis Biotherapeutics
10.2.1 Concortis Biotherapeutics Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.2.4 Antibody-drug Conjugate Product Introduction
10.2.5 Concortis Biotherapeutics Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.3.4 Antibody-drug Conjugate Product Introduction
10.3.5 Sanofi Recent Development
10.4 Celldex Therapeutics
10.4.1 Celldex Therapeutics Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.4.4 Antibody-drug Conjugate Product Introduction
10.4.5 Celldex Therapeutics Recent Development
10.5 Synthon Holding BV
10.5.1 Synthon Holding BV Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.5.4 Antibody-drug Conjugate Product Introduction
10.5.5 Synthon Holding BV Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antibody-drug Conjugate Sales Channels
11.2.2 Antibody-drug Conjugate Distributors
11.3 Antibody-drug Conjugate Customers
12 Market Forecast
12.1 Global Antibody-drug Conjugate Sales and Revenue Forecast 2019-2025
12.2 Global Antibody-drug Conjugate Sales Forecast by Type
12.3 Global Antibody-drug Conjugate Sales Forecast by Application
12.4 Antibody-drug Conjugate Forecast by Regions
12.4.1 Global Antibody-drug Conjugate Sales Forecast by Regions 2019-2025
12.4.2 Global Antibody-drug Conjugate Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
